In 2019, we officially inaugurated our Innovation Hub in Boston, Massachusetts. This area of the US is home to more than 1,000 biotech companies, as well as some of the world’s leading universities, and is a thriving centre for innovation in pain medicines.

Our Innovation Hub, known as Grünenthal Therapeutics, is a collaborative scientific site where our teams join forces with world-leading researchers, universities and companies. From drug discovery through to proof of concept, our team works together with partners to discover and develop new medicines for patients suffering from painful conditions.

Grünenthal Therapeutics
Cambridge Innovation Center, 14th floor
1 Broadway,
Cambridge MA 02142, USA